Did you know that, according to the Vascular Disease Foundation, about 27% of adults in the United States have been diagnosed with a form of venous disease in their legs? And of those conditions, two of the most common are largely superficial in nature: spider veins and varicose veins.
That being said, our team is exceptionally skilled in restoring both our patients’ comfort and confidence by way of superficial venous disease treatment.
When a patient’s blood flow begins to slow and stagnate in an area, the resulting pools will generate venous blemishes known as spider veins. The more these veins twist and become filled with slowly-circulating blood, the more saturated and visible they will appear.
Named for their web-like appearance, spider veins most commonly occur in the legs and thighs. Women are also statistically more likely to develop them than men.
Often developing in a patients’ legs, varicose veins emerge as twisted veins, often bulging through the skin. Generally, these veins are the result of weakened valves and poorly-functioning blood flow.
While they are primarily considered a cosmetic blemish for the fact that they are not a serious medical condition and do not always cause physical discomfort, they can lead to worsened venous conditions if not screened and treated adequately.
Sclerotherapy is the most common treatment for spider veins today. Non-surgical in nature, this treatment utilizes a sclerosant — or chemical-based irritant — which is injected into the spider veins. As it irritates the lining of the afflicted blood vessels, they will collapse and cause the blood flow to be rerouted through the healthier veins nearby. Thus, the body’s blood circulation is improved and surface-level blemishes are reduced or eliminated.
On average, patients require about two to five treatments overall before the sclerotherapy process is complete.
Venaseal™ is an innovative and FDA-approved method for closing poorly-functioning veins. Working similarly to that of sclerotherapy, Venaseal™ requires a physician to inject a solution into a patient’s veins — only this one is a medically-formulated adhesive agent. Venaseal™ is also revolutionary in that it requires no anesthesia in addition to minimal bruising and post-procedure downtime
Varithena® is a minimally-invasive means for treating superficial venous diseases. Specifically, Varithena® utilizes state-of-the-art microfoam technology, which is designed to safely collapse unhealthy veins. Once the microfoam interacts with the blood vessel lining to generate ablation, the foam is pushed out of the vein and distributed throughout the connected vessels, thereby collapsing other poorly-functioning veins along the way and dissolving harmlessly into the bloodstream of healthy veins.
Functioning similarly to that of EVLT, Radiofrequency Ablation (RF Ablation) also utilizes energy to collapse varicose veins. In this case, however, the doctor will use a catheter to insert a fiber that delivers short bursts of radiofrequency energy. These bursts effectively ablate the veins and
restore a more efficient flow of blood.
Both RF ablation and EVLT are minimally-invasive, requiring only a small incision through which the doctor will insert the catheter.